The Effect of Motivational Interviewing-Based Education on Treatment Adherence and Self-Care Agency in COPD Patients

NCT06733662 | Recruiting

• 1 other identifier: IstiklalU-YSazak-003
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

This randomized controlled trial will be conducted to evaluate the effect of education and motivational interviewing on treatment adherence and self-care power in COPD patients. Hypotheses of the Study; H1: Education and motivational interviewing in COPD patients increase treatment adherence in patients. H2: Education and motivational interviewing in COPD patients increase self-care power in patients. There will be two groups in the study: control and intervention groups. Before the intervention, pre-test data will be collected in the control and intervention groups. After the intervention, post-test data will be collected in both groups in line with the data collection forms.

Conditions

Motivational Interviewing; COPD

Keywords

Self-care; Treatment adherence; Education

Outcome Measures

Primary Outcomes (4)

• Morisky 8-item Medication Adherence Scale

  It is a scale that assesses self-reported medication use behaviors of the patient. It consists of eight questions. A validation study in Turkish was conducted by Oğuzülgen et al. in 2014. While the first seven questions are answered as "yes/no", the eighth question is answered on a five-point Likert scale as "never/rarely", "sometimes", "sometimes", "usually" and "always". Morisky 8-item medication adherence scale is calculated between 0-8 points.

  0 days

• Morisky 8-item Medication Adherence Scale

  It is a scale that assesses self-reported medication use behaviors of the patient. It consists of eight questions. A validation study in Turkish was conducted by Oğuzülgen et al. in 2014. While the first seven questions are answered as "yes/no", the eighth question is answered on a five-point Likert scale as "never/rarely", "sometimes", "sometimes", "usually" and "always". Morisky 8-item medication adherence scale is calculated between 0-8 points.

  30 days

• Self-care Agency Scale

  The scale was developed by Kearney and Fleischer and its validity and reliability study in Turkey was conducted by Nahcivan in 1993. In Nahcivan's study, the Cronbach's alpha coefficient of the scale was found to be 0.92. This scale, in which individuals self-assess their ability or power to perform self-care actions, consists of 35 items. The maximum score to be obtained from the scale is 140. As the score obtained from the scale increases, the self-care power of the patients also increases.

  0 days

• Self-care Agency Scale

  The scale was developed by Kearney and Fleischer and its validity and reliability study in Turkey was conducted by Nahcivan in 1993. In Nahcivan's study, the Cronbach's alpha coefficient of the scale was found to be 0.92. This scale, in which individuals self-assess their ability or power to perform self-care actions, consists of 35 items. The maximum score to be obtained from the scale is 140. As the score obtained from the scale increases, the self-care power of the patients also increases.

  30 days

Study Arms (2)

Education-based motivational interviewing Group

EXPERIMENTAL

Patients in the intervention group will be given COPD education lasting approximately 45-50 minutes in a single session in line with the education booklet and by evaluating the pre-test data. On the 3rd day, the first session of motivational interview will be held. On the 5th day and 7th day and 15th day, motivational interview sessions will continue with the patients.

Behavioral: Experimental: Education-based motivational interviewing Group

Control group

NO INTERVENTION

There will be no intervention for individuals in this group.

Interventions

Experimental: Education-based motivational interviewing Group BEHAVIORAL

The Effect of Motivational Interviewing-Based Education on Treatment Adherence and Self-Care Agency in COPD Patients

Education-based motivational interviewing Group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Confirmed diagnosis of COPD for at least 6 months
• Admitted to the chest clinic
• No communication problems
• Patients who volunteered to participate in the study.

You may not qualify if:

• In the period of exacerbation
• Uncooperative due to dyspnea
• With a malignant disease
• Patients with a confirmed diagnosis of psychiatric illness

Sponsors & Collaborators

• Kahramanmaraş İstiklal University: lead

Study Sites (1)

Kahramanmaraş Istiklal Universty

Kahramanmaraş, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive; Treatment Adherence and Compliance

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Health Behavior; Behavior

Central Study Contacts

Yasemin SAZAK

CONTACT

541 447 49 44; yasemin.sazak@istiklal.edu.tr

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor

Study Record Dates

• First Submitted: December 10, 2024
• First Posted: December 13, 2024
• Study Start: August 15, 2024
• Primary Completion: January 10, 2025
• Study Completion: February 15, 2025
• Last Updated: December 13, 2024

Record last verified: 2024-12

Locations

TU (1)